tiprankstipranks
Trending News
More News >
Bionano Genomics (BNGO)
:BNGO
US Market
Advertisement

BioNano Genomics (BNGO) Earnings Dates, Call Summary & Reports

Compare
9,214 Followers

Earnings Data

Report Date
Mar 05, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-1.36
Last Year’s EPS
-12.14
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 13, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth, record flow cell sales, and improved gross margins, with significant reductions in operating expenses. However, challenges include limited new system installations and slow market evolution in Japan. Cash reserves are solid, but a portion is restricted.
Company Guidance
In the third quarter of 2025, Bionano reported a total revenue of $7.4 million, marking a 21% increase compared to the same period in 2024. When adjusted for a prior $0.5 million write-down, core revenues grew 12% year-over-year. The company sold an all-time record of 8,390 flow cells, reflecting a 7% increase from the previous year, driven by increased utilization among routine users. Non-GAAP gross margin rose to 46%, up from 26% in Q3 2024, and operating expenses decreased by 40% to $9.7 million. The installed base expanded with seven new systems and a net increase of three, totaling 384 systems. The company ended the quarter with $31.8 million in cash and equivalents, following a $10 million public offering in September. Bionano reiterated its full-year revenue guidance of $26 million to $30 million and expects Q4 revenues between $7.5 million and $7.9 million.
Revenue Growth
Total revenue for Q3 2025 was $7.4 million, reflecting an increase of 21% compared to Q3 2024.
Flow Cells Sales Record
Sold an all-time record of 8,390 flow cells in Q3 2025, a 7% increase compared to the same period last year.
Gross Margin Improvement
Non-GAAP gross margin for Q3 2025 was 46%, up from 26% in Q3 2024.
Operating Expense Reduction
Non-GAAP operating expense for Q3 2025 was $9.7 million, a 40% reduction compared to $16.1 million in Q3 2024.
Cash Position Strengthened
Ended Q3 2025 with $31.8 million in cash, cash equivalents, and available-for-sale securities.
Expansion of Optical Genome Mapping (OGM)
97 new publications in Q3 2025 demonstrated the value of OGM, a 10% growth over the same period last year.

BioNano Genomics (BNGO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

BNGO Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 05, 2026
2025 (Q4)
-1.36 / -
-12.135
Nov 13, 2025
2025 (Q3)
-2.08 / -2.04
-31.293.46% (+29.16)
Aug 14, 2025
2025 (Q2)
-2.66 / -2.00
-14.486.11% (+12.40)
May 14, 2025
2025 (Q1)
- / -
-36
Mar 31, 2025
2024 (Q4)
-3.02 / -1.15
-3696.81% (+34.85)
Nov 13, 2024
2024 (Q3)
-11.85 / -31.20
-193.283.85% (+162.00)
Aug 07, 2024
2024 (Q2)
-24.92 / -14.40
-74.480.65% (+60.00)
May 08, 2024
2024 (Q1)
-38.65 / -36.00
-7250.00% (+36.00)
Mar 05, 2024
2023 (Q4)
-52.24 / -66.90
-7814.23% (+11.10)
Nov 08, 2023
2023 (Q3)
-58.18 / -193.20
-66-192.73% (-127.20)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

BNGO Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 13, 2025
$1.47$1.52+3.40%
Aug 14, 2025
$3.21$3.04-5.30%
May 14, 2025
$3.74$3.93+5.08%
Mar 31, 2025
$2.79$3.10+11.11%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Bionano Genomics (BNGO) report earnings?
Bionano Genomics (BNGO) is schdueled to report earning on Mar 05, 2026, After Close (Confirmed).
    What is Bionano Genomics (BNGO) earnings time?
    Bionano Genomics (BNGO) earnings time is at Mar 05, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is BNGO EPS forecast?
          BNGO EPS forecast for the fiscal quarter 2025 (Q4) is -1.36.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis